Synopsis
Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 3-rhamnosyl-glucosyl Quercetin
2. Quercetin 3 Rutinoside
3. Quercetin, 3-rhamnosyl-glucosyl
4. Quercetin-3-rutinoside
5. Rutoside
1. 153-18-4
2. Rutoside
3. Quercetin 3-rutinoside
4. Birutan
5. Phytomelin
6. Myrticolorin
7. Eldrin
8. Globulariacitrin
9. Rutin Trihydrate
10. Ilixanthin
11. Osyritrin
12. Paliuroside
13. Tanrutin
14. Sophorin
15. Bioflavonoid
16. Globularicitrin
17. Rutabion
18. Venoruton
19. 3-rutinosyl Quercetin
20. Violaquercitrin
21. Yunxianggan
22. 3-rhamnoglucosylquercetin
23. Rutine
24. Rutozyd
25. Melin
26. Quercetin 3-o-rutinoside
27. Rutinic Acid
28. Birutan Forte
29. Quercetin-3-rutinoside
30. Oxyritin
31. Rutinum
32. Rutosido
33. Rutosidum
34. Rutinion Acid
35. Vitamin P
36. Quercitin 3-rutinoside
37. Novarrutina
38. Violaquercetrin
39. Birutin
40. Quercetin Rhamnoglucosine
41. Quercetin-3-o-rutinoside
42. Quercetin-3beta-rutinoside
43. Quercetin 3-rhamnoglucoside
44. Quercetol 3-rhamnoglucoside
45. C.i. 75730
46. Rutosid
47. Rutoside [inn]
48. 3,3',4',5,7-pentahydroxyflavone-3-rutinoside
49. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
50. Quercetin 3-o-beta-d-rutinoside
51. 5g06tvy3r7
52. Chembl226335
53. Chebi:28527
54. Rutoside (inn)
55. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
56. 3-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
57. 3-rhamnoglucoside Of 3,3',4',5,7-pentahydroxyflavone
58. Ncgc00160628-01
59. Nsc-9220
60. Dsstox_cid_2326
61. Dsstox_rid_76549
62. Dsstox_gsid_22326
63. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
64. 4h-1-benzopyran-4-one,3-[[6-o-(6-deoxy-a-l-mannopyranosyl)-b-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
65. Rut
66. Rutoside (rutin)
67. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one
68. 3-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
69. Cas-153-18-4
70. Smr000112560
71. Rutin [jan:nf]
72. Rutosidum [inn-latin]
73. Rutosido [inn-spanish]
74. Usaf Cf-5
75. Unii-5g06tvy3r7
76. Neoisorutin
77. Ccris 7564
78. Rutinoside, Quercetin-3, Beta-
79. Hydroxyethylrutoside
80. Rutin (rutoside)
81. Venoruton (tn)
82. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-mannopyranoside
83. Nsc 9220
84. Einecs 205-814-1
85. Mfcd00006830
86. Rutin,(s)
87. Brn 0075455
88. 3,3',4',5,7-pentahydroxyflavone 3-rutinoside
89. Ai3-19098
90. Rutin [vandf]
91. Rutin [inci]
92. 207671-50-9
93. Rutin [dsc]
94. Rutin [usp-rs]
95. Rutin [mi]
96. Rutoside [inn:jan:nf]
97. Rutoside [who-dd]
98. Beta-quercetin-3-rutinoside
99. Bidd:pxr0020
100. Schembl23243
101. 4h-1-benzopyran-4-one, 3-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
102. 5-18-05-00519 (beilstein Handbook Reference)
103. Mls000759398
104. Mls001424098
105. Bidd:er0377
106. Divk1c_000644
107. Megxp0_000068
108. Rutin From Sophora Japonica L.
109. Dtxsid3022326
110. Acon1_000075
111. Cid_5280805
112. Hms502a06
113. Kbio1_000644
114. Rutin (95%)
115. Ninds_000644
116. 3,3',4',5,7-pentahydroxyflavone-3-rhamnoglucoside
117. Hms2051b06
118. 3'4'5,7-tetoh-flavone-3-rut
119. Flavone, 3,3',4',5,7-pentahydroxy-, 3-(o-rhamnosylglucoside)
120. Hy-n0148
121. Zinc4096846
122. Quercetin 3-o-beta-delta-rutinoside
123. Tox21_111945
124. Tox21_202602
125. Bdbm50217942
126. Glucopyranoside, Quercetin-3 6-o-alpha-l-rhamnopyranosyl-, Beta-d
127. Quercetin, 3-(6-o-alpha-l-rhamnopyranosyl-beta-d-glucopyranoside)
128. S2350
129. 3,3',4',5,5',7-hexahydroxyflavone (6-o-alpha-l-rhamnosyl-beta-d-glucoside)
130. Akos015895432
131. Glucopyranoside, Quercetin-3 6-o-(6-deoxy-alpha-l-mannopyranosyl)-, Beta-d-
132. Quercetin, 3-(6-0-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside)
133. Tox21_111945_1
134. Ccg-100999
135. Cs-5573
136. Db01698
137. Ds-9708
138. Nc00249
139. Idi1_000644
140. Rutinoside, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-1-benzopyran-3-yl
141. Ncgc00160628-02
142. Ncgc00160628-03
143. Ncgc00260150-01
144. 4h-1-benzopyran-4-one, 3-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
145. Methyltetrahydro-2h-pyran-2-yloxy)methyl)
146. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3
147. R0035
148. C05625
149. D08499
150. Ab00374708-09
151. Tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
152. A809400
153. Q407857
154. Sr-01000759399
155. Q-201691
156. Sr-01000759399-5
157. A8241da0-6ec6-48ba-bd10-3f7bd61d42ce
158. Brd-k20482099-001-01-1
159. Brd-k20482099-001-11-0
160. 3,3,4,5,7-pentahydroxyflavone-3-rhamnoglucoside
161. 3-rhamnoglucoside Of 5,7,3',4'-tetrahydroxyflavonol
162. Quercetin 3-o-[alpha-l-rhamnosyl-(1->6)-beta-d-glucoside]
163. Quercetin 3-o-.alpha.-l-rhamnopyranosyl-.beta.-d-glucopyranoside
164. Rutin (quercetin-3-o-rutinoside) (constituent Of Ginkgo) [dsc]
165. Rutin (quercetin-3-o-rutinoside) (constituent Of Hawthorn Leaf With Flower) [dsc]
166. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one;rutin
167. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)methyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
168. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4h-chromen-4-one
169. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-chromen-4-one-3-yl 6-o-.alpha.-l-rhamnopyranosyl-.beta.-d-glucoside
170. 4h-1-benzopyran-4-one, 3-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]-oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
| Molecular Weight | 610.5 g/mol |
|---|---|
| Molecular Formula | C27H30O16 |
| XLogP3 | -1.3 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 6 |
| Exact Mass | 610.15338487 g/mol |
| Monoisotopic Mass | 610.15338487 g/mol |
| Topological Polar Surface Area | 266 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 1020 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
C05CA01
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
C - Cardiovascular system
C05 - Vasoprotectives
C05C - Capillary stabilizing agents
C05CA - Bioflavonoids
C05CA01 - Rutoside
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Parenteral
Topical
Controlled & Modified Release
Fillers, Diluents & Binders
Film Formers & Plasticizers
Coating Systems & Additives
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
30
PharmaCompass offers a list of Rutin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rutin manufacturer or Rutin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rutin manufacturer or Rutin supplier.
PharmaCompass also assists you with knowing the Rutin API Price utilized in the formulation of products. Rutin API Price is not always fixed or binding as the Rutin Price is obtained through a variety of data sources. The Rutin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rutosid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rutosid, including repackagers and relabelers. The FDA regulates Rutosid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rutosid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rutosid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rutosid supplier is an individual or a company that provides Rutosid active pharmaceutical ingredient (API) or Rutosid finished formulations upon request. The Rutosid suppliers may include Rutosid API manufacturers, exporters, distributors and traders.
click here to find a list of Rutosid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rutosid DMF (Drug Master File) is a document detailing the whole manufacturing process of Rutosid active pharmaceutical ingredient (API) in detail. Different forms of Rutosid DMFs exist exist since differing nations have different regulations, such as Rutosid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rutosid DMF submitted to regulatory agencies in the US is known as a USDMF. Rutosid USDMF includes data on Rutosid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rutosid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rutosid suppliers with USDMF on PharmaCompass.
A Rutosid CEP of the European Pharmacopoeia monograph is often referred to as a Rutosid Certificate of Suitability (COS). The purpose of a Rutosid CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rutosid EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rutosid to their clients by showing that a Rutosid CEP has been issued for it. The manufacturer submits a Rutosid CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rutosid CEP holder for the record. Additionally, the data presented in the Rutosid CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rutosid DMF.
A Rutosid CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rutosid CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Rutosid suppliers with CEP (COS) on PharmaCompass.
A Rutosid written confirmation (Rutosid WC) is an official document issued by a regulatory agency to a Rutosid manufacturer, verifying that the manufacturing facility of a Rutosid active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rutosid APIs or Rutosid finished pharmaceutical products to another nation, regulatory agencies frequently require a Rutosid WC (written confirmation) as part of the regulatory process.
click here to find a list of Rutosid suppliers with Written Confirmation (WC) on PharmaCompass.
Rutosid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rutosid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rutosid GMP manufacturer or Rutosid GMP API supplier for your needs.
A Rutosid CoA (Certificate of Analysis) is a formal document that attests to Rutosid's compliance with Rutosid specifications and serves as a tool for batch-level quality control.
Rutosid CoA mostly includes findings from lab analyses of a specific batch. For each Rutosid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rutosid may be tested according to a variety of international standards, such as European Pharmacopoeia (Rutosid EP), Rutosid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rutosid USP).
